Recommendations for the diagnosis and treatment of glucocorticoid-induced osteoporosis
Tanaka, I.; Oshima, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 663-667
2004
ISSN/ISBN: 0047-1852 PMID: 15035205 Document Number: 569264
Document emailed within 1 workday
Related Documents
Miki, T.; Okamoto, K. 2014: Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis Clinical Calcium 24(9): 1387-1392Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Tałałaj, M.; Gradowska, L.; Marcinowska-Suchowierska, E.; Durlik, M.; Gaciong, Z.; Lao, M. 1996: Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients Transplantation Proceedings 28(6): 3485-3487
Yamamoto, M.; Sugimoto, T. 2014: Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis Clinical Calcium 24(9): 1379-1385
Lukert, B.P.; Raisz, L.G. 1994: Glucocorticoid-induced osteoporosis Rheumatic Diseases Clinics of North America 20(3): 629-650
Ohnaka, K.; Takayanagi, R. 2006: Glucocorticoid-induced osteoporosis Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl 2: 87-91
Den Uyl, D.; Bultink, I.E.M.; Lems, W.F. 2011: Glucocorticoid-induced osteoporosis Clinical and Experimental Rheumatology 29(5 Suppl 68: S93-S98
Chiodini, I.; Francucci, C.M.; Scillitani, A. 2008: Densitometry in glucocorticoid-induced osteoporosis Journal of Endocrinological Investigation 31(7 Suppl): 33-37
Tanaka, Y. 2006: Prophylaxis of glucocorticoid-induced osteoporosis Clinical Calcium 16(11): 1858-1865
Tomita, A. 1998: Glucocorticoid-induced osteoporosis--mechanisms and preventions Nihon Rinsho. Japanese Journal of Clinical Medicine 56(6): 1574-1578
Minisola, S.; Scillitani, A.; Romagnoli, E. 2006: Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis New England Journal of Medicine 355(20): 2156-2157; Author Reply 2157
Lombardi, G.; Colarusso, S.; Di Somma, C.; Guerra, E.; Tauchmanova, L.; Colao, A. 2008: The role of growth hormone in glucocorticoid-induced osteoporosis Journal of Endocrinological Investigation 31(7 Suppl): 38-42
Lidofsky, S.; Smith, J. 2009: Glucocorticoid-induced osteoporosis in inflammatory bowel disease Medicine and Health Rhode Island 92(4): 128-130
Khan, Y.K.; Kalaaji, A.N.; Clarke, B.L. 2008: Glucocorticoid-induced osteoporosis in dermatologic practice: a review Journal of Drugs in Dermatology: Jdd 7(11): 1053-1059
Tanaka, I.; Oshima, H. 2007: Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis Clinical Calcium 17(11): 1738-1744
Masaki, H.; Miki, T. 2006: Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP) Clinical Calcium 16(11): 1823-1832
Benucci, M.; Dolenti, S.; Saviola, G.; Manfredi, M. 2006: Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate Recenti Progressi in Medicina 97(1): 24-27
Lange, U.; Illgner, U.; Teichmann, J.; Schleenbecker, H. 2004: Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study International Journal of Clinical Pharmacology Research 24(2-3): 33-38
Freehill, A.K.; Lenke, L.G. 1999: Severe kyphosis secondary to glucocorticoid-induced osteoporosis in a young adult with Cushing's disease. A case report and literature review Spine 24(2): 189-193
2003: Recommendations for clinical practice. Review of diagnosis and treatment of migraine in the adult and child October 2002. Professional recommendations and references: economic evaluation service Revue Neurologique (Paris) 159(6-7 Part 2): S5-15